DAWN
Day One Biopharmaceuticals Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$21.31
+0.04 ▲ +0.19%
🌙 3월 13일 7:49 PM ET (한국 3/14 08:49)
$21.25
-0.06 ▼ -0.28%
| Index | RUT | P/E | - | EPS (ttm) | -1.04 | Insider Own | 26.57% | Shs Outstand | 0.10B | Perf Week | 0.52% |
| Market Cap | 2.20B | Forward P/E | - | EPS next Y | 76.31% | Insider Trans | -0.23% | Shs Float | 0.08B | Perf Month | 89.76% |
| Enterprise Value | 1.76B | PEG | - | EPS next Q | -0.28 | Inst Own | 68.65% | Short Float | 13.39% | Perf Quarter | 150.41% |
| Income | -0.11B | P/S | 13.92 | EPS this Y | 25.02% | Inst Trans | -6.62% | Short Ratio | 2.36 | Perf Half Y | 189.15% |
| Sales | 0.16B | P/B | 4.97 | EPS next 5Y | - | ROA | -19.68% | Short Interest | 10.15M | Perf YTD | 128.65% |
| Book/sh | 4.28 | P/C | 4.99 | EPS past 3/5Y | 21.77% -9.72% | ROE | -22.74% | 52W High | -0.56% ($21.43) | Perf Year | 144.94% |
| Cash/sh | 4.27 | P/FCF | - | Sales past 3/5Y | - | ROIC | -24.18% | 52W Low | 278.17% ($5.64) | Perf 3Y | 13.77% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | -0.47% | Gross Margin | 89.12% | Volatility(W/M) | 0.52% 5.31% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | 11.15 | Sales Y/Y TTM | 20.6% | Oper. Margin | -80.76% | ATR (14) | 1 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 7.91 | EPS Q/Q | 68.21% | Profit Margin | -67.85% | RSI (14) | 82.57 | Recom | 3 |
| Dividend Gr. 3/5Y | - | Current Ratio | 8.02 | Sales Q/Q | 83.92% | SMA20 | 47.87% ($14.41) | Beta | -1.59 | Target Price | $21.5 |
| Payout | - | Debt/Eq | 0.01 | Earnings | 2000000 | SMA50 | 74.02% ($12.25) | Rel Volume | 1.19 | Prev Close | $21.27 |
| Employees | 178 | LT Debt/Eq | 0.01 | EPS/Sales Surpr. | -41.03% 7.75% | SMA200 | 146.2% ($8.66) | Avg Volume(3M) | 4.30M | Price | $21.31 |
| IPO | 2021/5/27 | Option/Short | Yes/Yes | Trades | 13636 | Volume | 5,101,598 | Change | 0.19% |
뉴스 로딩 중...